Pharmacokinetics and Pharmacodynamics of Cephalosporins in Cerebrospinal Fluid

被引:0
|
作者
Irja Lutsar
Ian R. Friedland
机构
[1] Pfizer Global Research & Development Ltd,Sandwich Laboratories
[2] Merck & Co. Inc.,Merck Research Laboratories
来源
Clinical Pharmacokinetics | 2000年 / 39卷
关键词
Meningitis; Cephalosporin; Ceftriaxone; Cefotaxime; Bacterial Meningitis;
D O I
暂无
中图分类号
学科分类号
摘要
Largely because of their low lipophilicity, cephalosporins poorly penetrate through the blood-brain barrier, achieving relatively low cerebrospinal fluid (CSF) concentrations. However, the minimum bactericidal concentrations (MBCs) of the extended spectrum cephalosporins for common meningeal pathogens are generally low; thus, therapeutic CSF drug concentrations several-fold greater than the MBC can be achieved with currently recommended dosage regimens. However, the effectiveness of cephalosporin therapy is unreliable in patients with meningitis caused by highly penicillin-resistant pneumococci.
引用
收藏
页码:335 / 343
页数:8
相关论文
共 50 条
  • [41] Indinavir population pharmacokinetics in plasma and cerebrospinal fluid
    Letendre, SL
    Cappirelli, EV
    Ellis, RJ
    McCutchan, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) : 2173 - 2175
  • [42] PHARMACOKINETICS OF VINCRISTINE IN THE CEREBROSPINAL-FLUID OF HUMANS
    JACKSON, DV
    SETHI, VS
    SPURR, CL
    MCWHORTER, JM
    CANCER RESEARCH, 1981, 41 (04) : 1466 - 1468
  • [43] Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy
    Morikawa, N
    Mori, T
    Kawashima, H
    Takeyama, M
    Abe, T
    Kobayashi, H
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (04) : 436 - 438
  • [44] Pharmacokinetics and pharmacodynamics of linezolid in plasma/cerebrospinal fluid in patients with cerebral hemorrhage after lateral ventricular drainage by Monte Carlo simulation
    Wu, Xiaofei
    Tang, Yan
    Zhang, Xiaohua
    Wu, Chenchen
    Kong, Lingti
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1679 - 1684
  • [45] PHARMACOKINETICS AND METABOLISM OF CEPHALOSPORINS
    GRANINGER, W
    WIENER KLINISCHE WOCHENSCHRIFT, 1983, 95 : 11 - 15
  • [46] Comparison of serum, cerebrospinal fluid and brain extracellular fluid pharmacokinetics of lamotrigine
    Walker, MC
    Tong, X
    Perry, H
    Alavijeh, MS
    Patsalos, PN
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (02) : 242 - 248
  • [47] PHARMACOKINETICS OF ORAL CEPHALOSPORINS
    FINKELSTEIN, ER
    QUINTILIANI, R
    NIGHTINGALE, CH
    JOURNAL OF PEDIATRICS, 1978, 93 (05): : 902 - 902
  • [48] PHARMACOKINETICS OF CEPHALOSPORINS IN RABBITS
    KLIMOVA, VS
    RUDZIT, EA
    YAKOVLEV, VP
    ANTIBIOTIKI, 1981, 26 (04): : 284 - 287
  • [49] The pharmacokinetics of oral cephalosporins
    Mazzei, T
    Dentico, P
    CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 : 53 - 54
  • [50] PHARMACOKINETICS OF VINCRISTINE IN THE CEREBROSPINAL-FLUID OF SUBHUMAN PRIMATES
    JACKSON, DV
    CASTLE, MC
    POPLACK, DG
    BENDER, RA
    CANCER RESEARCH, 1980, 40 (03) : 722 - 724